| # | Drug | Count |
|---|---|---|
| 0 | LETROZOLE | 41 |
| 1 | LETROZOLE TABLETS | 32 |
| 2 | CAPECITABINE | 25 |
| 3 | FULVESTRANT | 23 |
| 4 | RIBOCICLIB | 22 |
| 5 | PALBOCICLIB | 20 |
| 6 | DABRAFENIB | 19 |
| 7 | TRAMETINIB | 19 |
| 8 | PACLITAXEL | 18 |
| 9 | EVEROLIMUS | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEMECLOCYCLINE | 1 | 0.0044 |
| 1 | NALDEMEDINE | 5 | 0.0030 |
| 2 | BARICITINIB | 4 | 0.0013 |
| 3 | MIGLITOL | 1 | 0.0010 |
| 4 | ECHINACEA ANGUSTIFOLIA, HAMAMMELIS VIRGINIANA, CALCAREA PHOSPHORICA, HYDRASTIS CANADANESIS, SENEGA OFFICINALIS, SILICEA, CONIUM, AURUM MURIATICUM NATRONATUM, CALCAREA CARBONICA, FUCUS VESICULOSUS, LACHESIS MUTUS | 1 | 0.0009 |
| 5 | DABRAFENIB | 19 | 0.0009 |
| 6 | VINORELBINE | 6 | 0.0009 |
| 7 | LUTETIUM LU 177 DOTATATE | 5 | 0.0009 |
| 8 | TOPOTECAN | 5 | 0.0008 |
| 9 | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 63 |
| 1 | Aromatase Inhibitor [EPC] | 54 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 33 |
| 3 | Platinum-based Drug [EPC] | 28 |
| 4 | Corticosteroid [EPC] | 24 |
| 5 | Estrogen Receptor Antagonist [EPC] | 24 |
| 6 | Microtubule Inhibitor [EPC] | 22 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 8 | mTOR Inhibitor Immunosuppressant [EPC] | 17 |
| 9 | Proton Pump Inhibitor [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 24 | 0.0006 |
| 1 | Aromatase Inhibitor [EPC] | 54 | 0.0005 |
| 2 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 5 | Programmed Death Ligand-1 Blocker [EPC] | 5 | 0.0002 |
| 6 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 8 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 2 | 0.0001 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 9 | 0.0001 |